Corrigendum to “Risk factors for reactivation of clinical...

  • Main
  • 2020 / 4
  • Corrigendum to “Risk factors for reactivation of clinical...
Multiple Sclerosis and Related Disorders 2020 / 4

Corrigendum to “Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation” [Multiple Sclerosis and Related Disorders 38 (2020) 101498]

Mustonen, Tiina, Rauma, Ilkka, Hartikainen, Päivi, Krüger, Johanna, Niiranen, Marja, Selander, Tuomas, Simula, Sakari, Remes, Anne M., Kuusisto, Hanna
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Multiple Sclerosis and Related Disorders
DOI:
10.1016/j.msard.2020.102107
Date:
April, 2020
File:
PDF, 144 KB
2020
Conversion to is in progress
Conversion to is failed